Magdalena Rogalska-Taranta

Magdalena Rogalska-Taranta is a PhD researcher at the Biotech Research & Innovation Centre (BRIC) of the University of Copenhagen, working within the Andersen Group. Her research focuses on liver diseases, hepatitis, and cancer biology, with particular emphasis on molecular mechanisms and clinical implications.

Her research interests encompass multiple facets of hepatology and immunology. Rogalska-Taranta investigates epigenomic factors in bile duct cancer, viral hepatitis mechanisms, immune responses in liver diseases, and biomarker discovery for disease progression and treatment response. Her work bridges basic science with clinical applications, particularly in understanding how molecular pathways affect patient outcomes in liver diseases.

Analysis of her publication record reveals a strong focus on translational hepatology research, with particular attention to hepatitis C and B viral infections, liver cancer mechanisms, and immune system interactions. Her work demonstrates consistent collaboration with clinical hepatologists and immunologists across European institutions, contributing to both fundamental understanding of disease mechanisms and clinical management approaches.

Her research group affiliations include the Andersen Group at BRIC, University of Copenhagen, where she contributes to cutting-edge research in liver disease pathogenesis and therapeutic development. The group maintains strong connections with clinical hepatology departments and research networks across Europe.